Jakub Klapaczynski
Warsaw, MZ 02507, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Are Direct-Acting Antivirals Effective and Safe for Hepatitis C Patients with Arterial Hypertension? Evidence from a Large Retrospective Real-World Study.
Journal: Viruses
Published: June 25, 2026
Does rheumatoid arthritis affect the course of chronic hepatitis C and outcomes of antiviral treatment?
Journal: Polish archives of internal medicine
Published: April 14, 2026
Clinical characteristics of patients with primary biliary cholangitis treated with ursodeoxycholic acid.
Journal: Polish archives of internal medicine
Published: July 24, 2025
Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs.
Journal: World journal of hepatology
Published: February 10, 2025
Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes.
Journal: Scientific reports
Published: December 23, 2024
Treatment of Hepatitis C Virus Infections Among Patients of Ukrainian Origin During the Influx of War Refugees to Poland.
Journal: Journal of clinical medicine
Published: October 27, 2024
Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination.
Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination.
Journal: BMC medicine
Published: September 03, 2024
Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices.
Journal: Pharmacological reports : PR
Published: May 03, 2024
Treatment of HCV infection in patients with steatotic liver disease.
Journal: Clinical and experimental hepatology
Published: April 17, 2024
Last Updated: 09/26/2026